Table 4.
Comparative analysis of the proportions of cases with the three individual molecular forms of uNGAL across the different groups
| Monomer | Dimer | NGAL/MMP-9 (+) | |
|---|---|---|---|
|
RF(all) |
73.1% (30/41) |
26.8% (11/41) |
50% (20/40) |
|
RF- |
42.5% (17/40) |
22.5% (9/40) |
85.3% (35/41) |
|
p
|
0.005* |
0.651 |
0.001* |
|
PYU(all) |
69.4% (25/36) |
41.2% (15/36) |
77.8% (28/36) |
|
PYU- |
48.9% (22/45) |
11.1% (5/45) |
60% (27/45) |
|
p
|
0.063 |
0.002* |
0.89 |
|
RF |
75% (18/24) |
20.8% (5/24) |
79.1% (19/24) |
|
PYU |
68.4% (13/19) |
47.4% (9/19) |
63.6% (12/19) |
|
p
|
0.633 |
0.065 |
0.245 |
|
RF-PYU |
70.1% (12/17) |
35.3% (6/17) |
94.1% (16/17) |
|
PYU |
68.4% (13/19) |
47.4% (9/19) |
63.6% (12/19) |
| p | 0.888 | 0.463 | 0.044* |
The data was analyzed by χ2 test. *indicates a significant difference - found (p<.05. RF (all) azotemia; PYU(all): pyuria; RF: azotemia without pyuria; RF-PYU: azotemia with pyuria; PYU: pyuria without azotemia.